| Followers | 1128 |
| Posts | 32739 |
| Boards Moderated | 2 |
| Alias Born | 01/11/2016 |
Wednesday, June 05, 2024 10:34:22 PM
He sold it for 300 million didn't he? Nothing came after that, if you are shareholder from when it was trading on Nasdaq, you should forward that question to the current management and ask them like you are asking me. Who knows, maybe he did his research and saw the ENZN with the previous management and their science wasn't going anywhere, these activists investors do their own research, not sure if it was a mistake or not, but they sold the assets for 300 million dollars, where is that money and where is the science. Biotech are hard one for sure, I personally love biotechs with promising science and I don't know enough about ENZN to know what his motive was to kill this former biotech, but based on the filings looks like they stopped the trials.
Recent ENZN News
- Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/25/2026 12:45:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/25/2026 12:38:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 12:36:13 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/25/2026 12:33:16 PM
- Enzon Announces Reverse Stock Split • GlobeNewswire Inc. • 03/24/2026 12:45:00 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/24/2026 12:35:53 PM
- Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/24/2026 12:33:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/24/2026 12:30:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 12:30:15 PM
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/19/2026 08:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/19/2026 08:18:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:16:32 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/19/2026 08:07:03 PM
- Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/18/2026 12:52:08 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/18/2026 12:48:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 12:45:26 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/16/2026 08:10:19 PM
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/16/2026 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:05:43 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/16/2026 08:00:54 PM
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/11/2026 12:45:00 PM
- Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/11/2026 12:39:23 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/11/2026 12:36:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 12:34:49 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/11/2026 12:31:05 PM
